Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Telomerase Activity in Thyroid Neoplasms Evaluated by the Expression of Human Telomerase Reverse Transcriptase (hTERT)

YASUHIRO ITO, HIROSHI YOSHIDA, CHISATO TOMODA, TAKASHI URUNO, YUUKI TAKAMURA, AKIHIRO MIYA, KAORU KOBAYASHI, FUMIO MATSUZUKA, KANJI KUMA and AKIRA MIYAUCHI
Anticancer Research January 2005, 25 (1B) 509-514;
YASUHIRO ITO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ito01@kuma-h.or.jp
HIROSHI YOSHIDA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHISATO TOMODA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKASHI URUNO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUUKI TAKAMURA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AKIHIRO MIYA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KAORU KOBAYASHI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FUMIO MATSUZUKA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KANJI KUMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AKIRA MIYAUCHI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Background: The recent availability of a monoclonal antibody against human telomerase reverse transcriptase (hTERT) has enabled us to investigate the telomerase activity of tissue specimens more easily than by classical TRAP assay. In this study, we studied teromerase activity in thyroid tumors using this antibody. Materials and Methods: We immunohistochemically investigated hTERT expression in 166 thyroid neoplasms. Results: Normal follicular cells did not express hTERT. In papillary carcinoma, high hTERT expression was observed in 34.5% of cases and it was directly linked to stage and the presence of lymph node metastasis. In follicular carcinoma, 39.2% were classified as the high hTERT expression group, showing a significantly higher incidence than that in follicular adenoma, 9.8%. In anaplastic carcinoma, 73.7% were regarded as the high hTERT expression group, which was larger than the percentages in papillary and follicular carcinomas. We investigated the diagnostic usefulness of hTERT measurement for discriminating follicular carcinoma from adenoma. Its specificity and positive predictive value were high at 90.2% and 83.3%, respectively, while the sensitivity and negative predictive value were low. Conclusion: These results suggest that: i) telomerase activity contributes to anaplastic transformation of differentiated carcinoma and ii) hTERT measurement may contribute to diagnosing follicular carcinoma, but whether it can be applied to preoperative diagnosis by fine-needle aspiration biopsy specimens remains unclear.

  • hTERT
  • follicular tumor
  • immunohistochemistry

Footnotes

  • Received July 16, 2004.
  • Accepted November 15, 2004.
  • Copyright© 2005 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
PreviousNext
Back to top

In this issue

Anticancer Research: 25 (1B)
Anticancer Research
Vol. 25, Issue 1B
1 Jan 2005
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Telomerase Activity in Thyroid Neoplasms Evaluated by the Expression of Human Telomerase Reverse Transcriptase (hTERT)
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Telomerase Activity in Thyroid Neoplasms Evaluated by the Expression of Human Telomerase Reverse Transcriptase (hTERT)
YASUHIRO ITO, HIROSHI YOSHIDA, CHISATO TOMODA, TAKASHI URUNO, YUUKI TAKAMURA, AKIHIRO MIYA, KAORU KOBAYASHI, FUMIO MATSUZUKA, KANJI KUMA, AKIRA MIYAUCHI
Anticancer Research Jan 2005, 25 (1B) 509-514;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Telomerase Activity in Thyroid Neoplasms Evaluated by the Expression of Human Telomerase Reverse Transcriptase (hTERT)
YASUHIRO ITO, HIROSHI YOSHIDA, CHISATO TOMODA, TAKASHI URUNO, YUUKI TAKAMURA, AKIHIRO MIYA, KAORU KOBAYASHI, FUMIO MATSUZUKA, KANJI KUMA, AKIRA MIYAUCHI
Anticancer Research Jan 2005, 25 (1B) 509-514;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Nuclear-specific accumulation of telomerase reverse transcriptase (TERT) mRNA in TERT promoter mutated follicular thyroid tumours visualised by in situ hybridisation: a possible clinical screening tool?
  • TERT promoter mutations in thyroid cancer
  • Deregulation of microRNA expression in follicular cell-derived human thyroid carcinomas
  • Micro-RNAs in thyroid neoplasms: molecular, diagnostic and therapeutic implications
  • Google Scholar

More in this TOC Section

  • Pelvic Recurrence After Curative Resection for Rectal Adenocarcinoma: Impact of Surgery on Survival
  • Glasgow Prognostic Score Predicts Survival and Recurrence Pattern in Patients With Hepatocellular Carcinoma After Hepatectomy
  • Small Bowel Lipomatosis: An Unusual Radiological Finding in Patients With Renal Cell Cancer on Pazopanib
Show more Clinical Studies

Similar Articles

Anticancer Research

© 2023 Anticancer Research

Powered by HighWire